Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
68.26
-0.39 (-0.57%)
Apr 10, 2026, 4:00 PM EDT - Market closed
Merit Medical Systems Revenue
In the year 2025, Merit Medical Systems had annual revenue of $1.52B with 11.75% growth. Merit Medical Systems had revenue of $393.94M in the quarter ending December 31, 2025, with 10.92% growth.
Revenue (ttm)
$1.52B
Revenue Growth
+11.75%
P/S Ratio
2.68
Revenue / Employee
$202,121
Employees
7,500
Market Cap
4.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.52B | 159.40M | 11.75% |
| Dec 31, 2024 | 1.36B | 99.14M | 7.88% |
| Dec 31, 2023 | 1.26B | 106.39M | 9.24% |
| Dec 31, 2022 | 1.15B | 76.23M | 7.09% |
| Dec 31, 2021 | 1.07B | 110.88M | 11.50% |
| Dec 31, 2020 | 963.88M | -30.98M | -3.11% |
| Dec 31, 2019 | 994.85M | 112.10M | 12.70% |
| Dec 31, 2018 | 882.75M | 154.90M | 21.28% |
| Dec 31, 2017 | 727.85M | 124.01M | 20.54% |
| Dec 31, 2016 | 603.84M | 61.69M | 11.38% |
| Dec 31, 2015 | 542.15M | 32.46M | 6.37% |
| Dec 31, 2014 | 509.69M | 60.64M | 13.50% |
| Dec 31, 2013 | 449.05M | 54.76M | 13.89% |
| Dec 31, 2012 | 394.29M | 34.84M | 9.69% |
| Dec 31, 2011 | 359.45M | 62.69M | 21.13% |
| Dec 31, 2010 | 296.76M | 39.29M | 15.26% |
| Dec 31, 2009 | 257.46M | 30.32M | 13.35% |
| Dec 31, 2008 | 227.14M | 19.38M | 9.33% |
| Dec 31, 2007 | 207.77M | 17.09M | 8.97% |
| Dec 31, 2006 | 190.67M | 24.09M | 14.46% |
| Dec 31, 2005 | 166.59M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Avantor | 6.55B |
| Bausch + Lomb | 5.10B |
| DENTSPLY SIRONA | 3.68B |
| Minimed Group | 2.89B |
| Envista Holdings | 2.72B |
| ICU Medical | 2.23B |
| Teleflex | 1.99B |
| Stevanato Group | 1.39B |
MMSI News
- 18 days ago - Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain - PRNewsWire
- 26 days ago - Merit Medical Launches the Resilience Through-the-Scope Esophageal Stent - GlobeNewsWire
- 3 months ago - Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025 - GlobeNewsWire
- 5 months ago - Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial - GlobeNewsWire
- 6 months ago - PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement - PRNewsWire
- 6 months ago - Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025 - GlobeNewsWire
- 6 months ago - Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology - GlobeNewsWire
- 7 months ago - Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis - GlobeNewsWire